Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases

Ann Rheum Dis. 2022 Feb;81(2):289-291. doi: 10.1136/annrheumdis-2021-221326. Epub 2021 Sep 6.

Claire Cook¹, Naomi J Patel^{1

2}, Kristin M D'Silva^{1

2}, Tiffany Y-T Hsu^{2

3}, Michael DiIorio^{2

3}, Lauren Prisco³, Lily W Martin³, Kathleen Vanni³, Alessandra Zaccardelli³, Derrick Todd^{2

3}, Jeffrey A Sparks^{2

3}, Zachary Scott Wallace^{4

2}

¹ Division of Rheumatology, Allergy, and Immunology and Clinical Epidemiology Program, Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Harvard Medical School, Boston, Massachusetts, USA.
³ Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
⁴ Division of Rheumatology, Allergy, and Immunology and Clinical Epidemiology Program, Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA zswallace@partners.org.

No abstract available

Keywords: COVID-19; autoimmune diseases; epidemiology; vaccination.

Publication types